from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2787/-

LFCtreatmentdescriptionclass of inhibitor

-0.063

Amikacinug/mL Amikacintranslation

0.279

Cap5-10ug/mL Capreomycintranslation

0.638

Rox10-50 ug/mL Roxithromycintranslation

0.770

SM2-5 ug/mL Streptomycintranslation

-1.830

Tet5-10 ug/mL Tetracyclinetranslation

0.462

Rif0.2-5ug/mL Rifampicintranscription

0.782

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.054

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.889

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.480

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.438

Clofazimine10-13 ug/mL Clofaziminerespiration

0.561

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.275

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.248

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.268

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.219

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.163

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.668

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.390

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.309

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.048

KCN5-20 ug/mL Potassium cyaniderespiration

0.997

NaN30.2-2 mM Sodium aziderespiration

0.284

Nigericin50 uM Nigericinrespiration

0.078

TRC10-150 ug/mL Triclosanrespiration

-0.502

TRZ10-25 ug/mL Thioridazinerespiration

-0.787

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.563

menadione6-10 ug/mL Menadionerespiration

0.149

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.231

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.445

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.315

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.118

NRP_1Non-replicating persistence stage 1dosRassociated

0.635

Amp0.2mg/mL AmpicillincellWall

0.010

Cephalexin20-100 ug/mL CephalexincellWall

1.634

Cerulenin0.32-5 ug/mL CerulenincellWall

0.385

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.761

EMB10-20 ug/mL EthambutolcellWall

0.451

Eta12-40 ug/mL EthionamidecellWall

0.679

INH0.2-0.4 ug/mL IsoniazidcellWall

0.203

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.991

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.024

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.265

BZA0.12 mg/mL BenzamidearomaticAmides

0.127

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.251

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.588

H2O24 mM hydrogen peroxideDNAdamaging

0.310

Levo10 ug/mL LevofloxacinDNAdamaging

0.071

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.636

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.827

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.062

UVUV-irradiationDNAdamaging

-1.286

ARP41-4 ug/mL Antitubercular compound ARP4?

0.420

Antimycin12.5-50 ug/mL Antimycin A?

-0.633

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.291

PA_110-50 ug/mL Antitubercular compound PA-1?

0.081

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.114

PA8240.2-2 ug/mL PA-824?

-1.444

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.282

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.859

Verapamil50 uM Verapamil?

-1.832

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.282

methoxatin10-20 ug/mL Methoxatin?